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ABSTRACT 
The 6-minute walk test (6MWT) has been used to predict mortality and measure clinical 
outcomes of trials in the patients with chronic cardiopulmonary disorders. 6MWT measures the 
distance that patients quickly walks for 6 min. In this study， we examined the accuracy of the 
walking steps during 6MWT by 3-dimensional accelerometer in pulse oximetry. We performed 
6MWT using pulse oximetry with 3-dimensional accelerometer in 9 healthy subjects and 2 
patients with chronic obstructive pulmonary disease. The steps m巴asuredby 3-dimensional 
acceleromet巴rwere strongly correlated with the steps manually counted (r = 0.983， p < 
0.0001). The predicted walking distance was also significantly correlated with the walking 
distance of 6MWT (r = 0.858， p < 0.0∞3). We confirmed the clinical efficacy of出isdevice. 
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図1 実測歩数と計測歩数の相関関係と回帰分析
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図2 実測歩行距離と予測歩行距離の相関関係と回帰分析
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